Verwiel Frank has filed 7 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 8000 shares of Intellia Therapeutics, Inc. ($NTLA) on June 11, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Not found | A | Common Stock | 8000 | $0.00 | 25,948.0000 | 103,517,460 | 44.57% | 0.01% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| June 17, 2024 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Not found | S | Common Stock | 1505 | $25.00 | 17,948.0000 | 0 | 7.74% | 0.00% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Not found | A | Common Stock | 7737 | $0.00 | 19,453.0000 | 0 | 66.04% | 0.00% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Director | A | Common Stock | 4425 | $0.00 | 11,716.0000 | 0 | 60.69% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Verwiel Frank | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |